Economic outcomes with anatomical versus functional diagnostic testing for coronary artery disease.
Annals of Internal Medicine.
Times cited: 27
High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: Outcomes at 6 months and 1 year in the SYNERGY trial.
JAMA - Journal of the American Medical Association.
Times cited: 60